Mga Batayang Estadistika
| CIK | 1476170 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Unilife Corp
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| October 30, 2017 |
EX-99.1 2 d482901dex991.htm EX-99.1 Exhibit 99.1 UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE In re Unilife Corporation, et al. [1] Case No. 17-10805 Reporting Period: Aug. 1 to Aug. 31, 2017 MONTHLY OPERATING REPORT File with Court and submit copy to United States Trustee within 20 days after end of month Submit copy of report to any official committee appointed in the case. REQUIRED DOCUM |
|
| October 30, 2017 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 19, 2017 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| October 30, 2017 |
EX-99.2 Exhibit 99.2 UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE In re Unilife Corporation, et al. [1] Case No. 17-10805 Reporting Period: Sept. 1 to Sept. 30, 2017 MONTHLY OPERATING REPORT File with Court and submit copy to United States Trustee within 20 days after end of month Submit copy of report to any official committee appointed in the case. Document Affidavit/Supplement REQUIRED D |
|
| September 11, 2017 |
EX-99.1 Exhibit 99.1 UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE In re Unilife Corporation, et al. [1] Case No. 17-10805 Reporting Period: July 1 to July 31, 2017 MONTHLY OPERATING REPORT File with Court and submit copy to United States Trustee within 20 days after end of month Submit copy of report to any official committee appointed in the case. REQUIRED DOCUMENTS Form No. Document Attac |
|
| September 11, 2017 |
Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2017 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 2, 2017 |
UNILIFE FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2017 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 2, 2017 |
EX-99.1 2 d433835dex991.htm EX-99.1 Exhibit 99.1 UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE In re Unilife Corporation, et al. [1] Case No. 17-10805 Reporting Period: June 1 to June 30, 2017 MONTHLY OPERATING REPORT File with Court and submit copy to United States Trustee within 20 days after end of month Submit copy of report to any official committee appointed in the case. Document Affid |
|
| August 2, 2017 |
UNIS / Unilife Corp / AMGEN INC - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* UNILIFE CORPORATION (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 90478E103 (CUSIP Number) July 24, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t |
|
| June 26, 2017 |
Case 17-10805-LSS Doc 229 Filed 06/22/17 Page 11 of 14 unis-ex9916.htm Exhibit 99.1 Case 17-10805-LSS Doc 229 Filed 06/22/17 Page 1 of 14 UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE In re Unilife Corporation, et al. [1Sect ion 1746) that this report and the attached documents are true and correct to the best of my knowledge and belief. Signature of Debtor Date Signature of Joint Debtor Date /s/ John Ryan June 22,2017 Signature of Authorized In |
|
| June 26, 2017 |
UNILIFE 8-K (Current Report/Significant Event) unis-8k20170622.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2017 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Co |
|
| June 14, 2017 |
UNILIFE 8-K (Current Report/Significant Event) unis-8k20170614.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 8, 2017 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Com |
|
| June 8, 2017 |
UNILIFE 8-K (Current Report/Significant Event) unis-8k20170605.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 5, 2017 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Com |
|
| June 2, 2017 |
IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE EX-99.1 2 unis-ex9916.htm EX-99.1 Exhibit 99.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE In re Unilife Corporation, et al. [1] Case No. 17-10805 (LSS) Reporting Period: April 12, 2017 to April 30, 2017 MONTHLY OPERATING REPORT File with Court and submit copy to United States Trustee within 20 days after end of month Submit copy of report to any official committee appointed |
|
| June 2, 2017 |
UNILIFE 8-K (Current Report/Significant Event) unis-8k20170601.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2017 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Com |
|
| May 10, 2017 |
UNILIFE 8-K (Current Report/Significant Event) unis-8k20170510.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2017 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Com |
|
| May 4, 2017 |
UNIS / Unilife Corp / JP Morgan Chase & Co Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G/A (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(c) ( AMENDMENT 5) UNILIFE CORPORATION ( NAME OF ISSUER ) Common Stock, par value $0. |
|
| April 27, 2017 |
UNILIFE 8-K (Current Report/Significant Event) unis-8k20170421.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2017 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or other jurisdiction of incorporation) (C |
|
| April 27, 2017 |
unis-ex1616.htm Exhibit 16.1 April 27, 2017 Securities and Exchange Commission Washington, D.C. 20549 Ladies and Gentlemen: We were previously principal accountants for Unilife Corporation (the Company) and, under the date of October 21, 2016, we reported on the consolidated financial statements of the Company as of and for the years ended June 30, 2016 and 2015, and the effectiveness of internal |
|
| April 17, 2017 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8-K 1 unis-8k20170418.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 12, 2017 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorpo |
|
| April 12, 2017 |
UNILIFE 8-K (Current Report/Significant Event) unis-8k20170412.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 12, 2017 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (C |
|
| April 12, 2017 |
Unilife Files for Chapter 11 Protection Operations Remain Ongoing During Process unis-ex9916.htm Exhibit 99.1 Unilife Files for Chapter 11 Protection Operations Remain Ongoing During Process King of Prussia, PA, April 12, 2017 /PRNewswire/ ? Unilife Corporation (?Unilife? and together with its domestic subsidiaries, the ?Company?) (NASDAQ: UNIS; ASX: UNS) today announced that it has commenced a formal proceeding to restructure its balance sheet or to sell its assets as a going |
|
| April 4, 2017 |
Costs Associated with Exit or Disposal Activities, Results of Operations and Financial Condition 8-K 1 unis-8k20170331.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 31, 2017 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorpo |
|
| March 27, 2017 |
unis-8k20170328.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 27, 2017 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (C |
|
| February 9, 2017 |
EX-99.1 Exhibit 99.1 UNILIFE CORPORATION ARBN 141 042 757 Appendix 4D ? Half Year Report Six months ended 31 December 2016 Results for announcement to the market UNILIFE CORPORATION HIGHLIGHTS Results for Announcement to the Market Six Months Ended 31 December 2016 US$000?s Six Months Ended 31 December 2015 US$000?s Revenues from ordinary activities Down 47.3 % to 4,053 7,686 Profit (loss) from or |
|
| February 9, 2017 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 9, 2017 (February 9, 2017) UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 9, 2017 |
Unilife UNIS-10Q2-20161231 (Quarterly Report) 10-Q 1 unis-10q20161231.htm UNIS-10Q2-20161231 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period f |
|
| February 9, 2017 |
tenth AMENDMENT TO CREDIT AGREEMENT Exhibit 10.5 tenth AMENDMENT TO CREDIT AGREEMENT This Tenth AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of December 20, 2016 by and among Unilife Medical Solutions, Inc., a Delaware corporation (the “Borrower”), the other Creditor Obligors party hereto and ROS Acquisition Offshore LP, a Cayman Islands exempted limited partnership (in its capacity as Lender and Coll |
|
| February 9, 2017 |
Awareness Letter from Independent Registered Public Accounting Firm EX-15 7 unis-ex15700.htm EX-15 Exhibit 15 Awareness Letter from Independent Registered Public Accounting Firm February 9, 2017 Unilife Corporation York, Pennsylvania Re: Registration Statements No. 333-197122, 333-164964, 333-178882, 333-186049, 333-193358, 333-200223 and 333-215751 With respect to the subject registration statements, we acknowledge our awareness of the use therein of our report d |
|
| February 9, 2017 |
UNILIFE CORPORATION 6% SENIOR SECURED CONVERTIBLE NOTE DUE 2023 Exhibit 10.2 Certain portions of this Exhibit have been omitted pursuant to a request for confidentiality. Such omitted portions, which are marked with brackets [] and an asterisk*, have been separately filed with the Commission. NEITHER THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH SUCH SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 |
|
| February 9, 2017 |
NINTH AMENDMENT TO CREDIT AGREEMENT Exhibit 10.4 NINTH AMENDMENT TO CREDIT AGREEMENT This NINTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of October 24, 2016 by and among UNILIFE MEDICAL SOLUTIONS, INC., a Delaware corporation (the “Borrower”), the other Creditor Obligors party hereto and ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership (in its capacity as Lender and Colla |
|
| February 9, 2017 |
Form of Accelerated Convertible Note Due 2023 Exhibit 10.1 Certain portions of this Exhibit have been omitted pursuant to a request for confidentiality. Such omitted portions, which are marked with brackets [] and an asterisk*, have been separately filed with the Commission. October 24, 2016 BY FACSIMILE AND FEDEX Amgen Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1799 Attention: Corporate Secretary (Fax: (805) 447-1010) Re: Accelerati |
|
| February 9, 2017 |
UNILIFE CORPORATION 6% SENIOR SECURED CONVERTIBLE NOTE DUE 2023 EX-10.3 4 unis-ex103168.htm EX-10.3 Exhibit 10.3 Certain portions of this Exhibit have been omitted pursuant to a request for confidentiality. Such omitted portions, which are marked with brackets [] and an asterisk*, have been separately filed with the Commission. NEITHER THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH SUCH SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTE |
|
| February 7, 2017 |
UNIS / Unilife Corp / AMGEN INC - FORM SC 13G/A Passive Investment Form SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* UNILIFE CORPORATION (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 90478E103 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to de |
|
| January 31, 2017 |
Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B EX-99.1 2 d157283dex991.htm EX-99.1 Exhibit 99.1 Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B +Rule 4.7B Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B Introduced 31/03/00 Amended 30/09/01, 24/10/05, 17/12/10, 01/09/16 Name of entity UNILIFE CORPORATION ABN Quarter ended (“current quarter”) 141 042 757 31 December 2016 Consolidated statement of cas |
|
| January 31, 2017 |
Unilife FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 31, 2017 (January 31, 2017) UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| January 26, 2017 |
unis-s8.htm As filed with the Securities and Exchange Commission on January 26, 2017 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 UNILIFE CORPORATION (Exact name of registrant as specified in its charter) Delaware 27-1049354 (State or other jurisdiction of incorporation or organization |
|
| December 20, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 20, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| December 20, 2016 |
Unilife Annual Shareholder Meeting John Ryan Remarks December 15, 2016 unis-ex9916.htm Exhibit 99.1 Unilife Annual Shareholder Meeting John Ryan Remarks December 15, 2016 Welcome everyone, thank you Mary Kate, and welcome Mike, Rose and Duane. I have about five minutes of remarks, then would welcome questions and comments. The board and management will be here after the meeting and we encourage you to meet them after the meeting. It has been a year of real transforma |
|
| December 20, 2016 |
Regulation FD Disclosure, Financial Statements and Exhibits unis-8ka20161220.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A AMENDMENT NO. 1 TO CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 15, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdic |
|
| December 16, 2016 |
unis-8k20161231.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 15, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) |
|
| December 15, 2016 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 unis-8k20161215.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 15, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Inco |
|
| December 15, 2016 |
Unilife Annual Shareholder Meeting John Ryan Remarks December 15, 2016 EX-99.1 2 unis-ex9916.htm EX-99.1 Exhibit 99.1 Unilife Annual Shareholder Meeting John Ryan Remarks December 15, 2016 Welcome everyone, thank you Mary Kate, and welcome Mike, Rose and Duane. I have about five minutes of remarks, then would welcome questions and comments. The board and management will be here after the meeting and we encourage you to meet them after the meeting. It has been a year |
|
| December 5, 2016 |
DEFA14A 1 unis-defa14a20161205.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by |
|
| November 17, 2016 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 d280444d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 17, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Inco |
|
| November 17, 2016 |
Industry-Leading Wearable Injectors, People and Partners EX-99.1 Exhibit 99.1 Industry-Leading Wearable Injectors, People and Partners November 17, 2016 Unilife Forward Looking Statements This presentation contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on manageme |
|
| November 14, 2016 |
Unilife UNIS-10Q-20160930 (Quarterly Report) 10-Q 1 unis-10q20160930.htm UNIS-10Q-20160930 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period f |
|
| November 14, 2016 |
EX-10.2 3 unis-ex102163.htm EX-10.2 Exhibit 10.2 July 28, 2016 BY FACSIMILE AND FEDEX Amgen Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1799 Attention: Corporate Secretary (Fax: (805) 447-1010) Re:Waiver of Rights Under SPA and Promissory Note Ladies and Gentlemen: Reference is made herein to that certain (i) Securities Purchase Agreement (the “SPA”), dated as of February 22, 2016, by and |
|
| November 14, 2016 |
Exhibit 10.1 AMGEN Amgen One Amgen Center Drive M/S 28-5-C Thousand Oaks, CA 91320-1799 805.447.1000 Fax: 805.499.6751 July 28,2016 Unilife Corporation 250 Cross Farm Lane York, PA 17406 Attention: John C. Ryan Facsimile No.: (717) 384-3402 Re: Convertible Notes Due 2023 Dear John: Reference is made to the Securities Purchase Agreement dated February 22, 2016 (the “Purchase Agreement”) among Unili |
|
| November 10, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 001-34540 CUSIP NUMBER: 90478E 103 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2016 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form. |
|
| November 7, 2016 |
EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT Exhibit 24.1 LIMITED POWER OF ATTORNEY FOR SECTION 16(a) REPORTING KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints Kevin Campbell and Stephanie Walters, as the undersigned's true and lawful attorney-in-fact (the "Attorney-in-Fact"), with full power of substitution and resubstitution, with the power to act al |
|
| November 7, 2016 |
Exhibit 24.1 LIMITED POWER OF ATTORNEY FOR SECTION 16(a) REPORTING KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints Kevin Campbell and Stephanie Walters, as the undersigned's true and lawful attorney-in-fact (the "Attorney-in-Fact"), with full power of substitution and resubstitution, with the power to act alone for the undersigned and in the undersig |
|
| November 2, 2016 |
Unilife Corporation Provides Business Update EX-99.1 Exhibit 99.1 Unilife Corporation Provides Business Update YORK, PA, November 2, 2016 / PR Newswire/ As previously announced, Unilife Corporation (Unilife or Company) (NASDAQ: UNIS; ASX: UNS) management is hosting a conference call to provide an operational and financial update today at 4:30 p.m. EDT (7:30 a.m. AEDT on Wednesday, November 3, 2016). John Ryan, Unilifes President and C |
|
| November 2, 2016 |
EX-99.2 Industry-Leading Wearable Injectors, People and Partners November 2, 2016 Exhibit 99.2 Forward Looking Statements This presentation contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beli |
|
| November 2, 2016 |
8-K 1 d300107d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 2, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incor |
|
| October 31, 2016 |
Appendix 4C (Amended) Quarterly report for entities admitted on the basis of commitments EX-99.3 Exhibit 99.3 Appendix 4C Quarterly report for entities admitted on the basis of commitments Rule 4.7B Appendix 4C (Amended) Quarterly report for entities admitted on the basis of commitments Introduced 31/3/2000. Amended 24/10/2005 Explanatory Note Unilife Corporation (the ?Company,? ?we,? ?our? or ?us?) is filing this Amended Appendix 4C for the fiscal quarter ended 31 March 2016. On 8 Ma |
|
| October 31, 2016 |
Appendix 4C (Amended) Quarterly report for entities admitted on the basis of commitments EX-99.6 Exhibit 99.6 Appendix 4C Quarterly report for entities admitted on the basis of commitments Rule 4.7B Appendix 4C (Amended) Quarterly report for entities admitted on the basis of commitments Introduced 31/3/2000. Amended 24/10/2005 Explanatory Note Unilife Corporation (the ?Company,? ?we,? ?our? or ?us?) is filing this Amended Appendix 4C for the fiscal quarter ended 30 June 2015. On 8 May |
|
| October 31, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 31, 2016 (October 31, 2016) UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| October 31, 2016 |
Appendix 4C (Amended) Quarterly report for entities admitted on the basis of commitments EX-99.4 Exhibit 99.4 Appendix 4C Quarterly report for entities admitted on the basis of commitments Rule 4.7B Appendix 4C (Amended) Quarterly report for entities admitted on the basis of commitments Introduced 31/3/2000. Amended 24/10/2005 Explanatory Note Unilife Corporation (the ?Company,? ?we,? ?our? or ?us?) is filing this Amended Appendix 4C for the fiscal quarter ended 31 December 2015. On 8 |
|
| October 31, 2016 |
Appendix 4C (Amended) Quarterly report for entities admitted on the basis of commitments Exhibit 99.2 Appendix 4C Quarterly report for entities admitted on the basis of commitments Rule 4.7B Appendix 4C (Amended) Quarterly report for entities admitted on the basis of commitments Introduced 31/3/2000. Amended 24/10/2005 Explanatory Note Unilife Corporation (the Company, we, our or us) is filing this Amended Appendix 4C for the fiscal quarter ended 30 June 2016. On 8 May 2016, t |
|
| October 31, 2016 |
Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B EX-99.1 Exhibit 99.1 Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B +Rule 4.7B Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B Introduced 31/03/00 Amended 30/09/01, 24/10/05, 17/12/10, 01/09/16 Name of entity UNILIFE CORPORATION ABN Quarter ended (current quarter) 141 042 757 30 September 2016 Consolidated statement of cash flows Current quarter $US |
|
| October 31, 2016 |
Appendix 4C (Amended) Quarterly report for entities admitted on the basis of commitments EX-99.5 Exhibit 99.5 Appendix 4C Quarterly report for entities admitted on the basis of commitments Rule 4.7B Appendix 4C (Amended) Quarterly report for entities admitted on the basis of commitments Introduced 31/3/2000. Amended 24/10/2005 Explanatory Note Unilife Corporation (the ?Company,? ?we,? ?our? or ?us?) is filing this Amended Appendix 4C for the fiscal quarter ended 30 September 2015. On |
|
| October 31, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 26, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| October 31, 2016 |
EX-99.1 2 d283571dex991.htm EX-99.1 Exhibit 99.1 Unilife Appoints Rosemary Crane and Duane DeSisto to its Board of Directors; Unilife Announces Date of 2016 Annual Meeting YORK, PA, October 31, 2016 / PR Newswire/ — Unilife Corporation (“Unilife” or the “Company”) (NASDAQ: UNIS; ASX: UNS) announced that Rosemary A. Crane and Duane M. DeSisto have joined the Company’s Board of Directors. The Compan |
|
| October 28, 2016 |
DEF 14A 1 unis-def14a20161215.htm DEF 14A absolutel UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as per |
|
| October 24, 2016 |
Unilife Announces Filing of 2016 10-K EX-99.1 2 d275318dex991.htm EX-99.1 Exhibit 99.1 Unilife Announces Filing of 2016 10-K • Company Now Current with SEC Filings • Internal Investigation Complete • Business Restructured to Prioritize Wearable Injector Customer Programs • Cost Reduction Measures Implemented • Amgen Accelerates Purchase of Initial $10 Million from $15 Million Convertible Note • Investor Conference Call Scheduled for W |
|
| October 24, 2016 |
Unilife FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 24, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| October 24, 2016 |
10-K 1 unis-10k20160630.htm 10K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-3454 |
|
| October 24, 2016 |
Unilife UNIS-10Q-20160331 (Quarterly Report) unis-10q20160331.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number |
|
| October 24, 2016 |
Exhibit 10.85 October 20, 2016 BY FACSIMILE, EMAIL AND FEDEX ROS Acquisition Offshore LP Attn: Neil Gray C/0 Walkers Corporate Services Limited Walker House, 87 Mary Street George Town, Grand Cayman KY 1-9005 Cayman Islands OrbiMed Advisors LLC Attn: Matthew Rizzo 601 Lexington Avenue, 54th Floor New York, NY 10022 Phone: 212.739.6400 Fax: 212.739.6444 Email: [email protected] RE:Waiver and Modif |
|
| October 24, 2016 |
Exhibit 10.79 August 29, 2012 Michael C. Ratigan 901 East Gate Road Kinnelon, NJ 07405 Re: Promotion to Senior Vice President and Chief Commercial Officer Dear Mike: I am pleased to offer you a promotion to Senior Vice President and Chief Commercial Officer for Unilife Medical Solutions. Your annual base salary as an exempt employee will be $285,000, effective March 1, 2012. Your potential cash bo |
|
| October 24, 2016 |
Exhibit 10.5 February 5, 2016 Amgen Inc. One Amgen Center Drive Thousand Oaks CA 91320-1799 Attention: Corporate Secretary Re: Amendment of Exclusivity Letter Ladies and Gentlemen: Unilife Corporation (“Unilife”) and Amgen Inc. (“Amgen” and, together with Unilife, the “Parties”) entered into an exclusivity letter agreement dated December 31, 2015 (the “Exclusivity Letter”). Capitalized terms used |
|
| October 24, 2016 |
UNILIFE CORPORATION 6% SENIOR SECURED CONVERTIBLE NOTE DUE 2023 Exhibit 10.14 Certain portions of this Exhibit have been omitted pursuant to a request for confidentiality. Such omitted portions, which are marked with brackets [] and an asterisk*, have been separately filed with the Commission. NEITHER THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH SUCH SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 193 |
|
| October 24, 2016 |
UNILIFE CORPORATION dated as of February 22, 2016 Exhibit 10.15 This Warrant was not issued pursuant to a disclosure document under Chapter 6D of the Australian Corporations Act 2001 (the “Corporations Act”) or a product disclosure statement under Chapter 7 of the Corporations Act. This Warrant may not be offered for resale within Australia within 12 months of it having been issued unless any such resale offer is exempt from the requirement to is |
|
| October 24, 2016 |
Exhibit 10.37 Grant No.: Restricted Stock Unit Notice Under the Unilife Corporation Amended And Restated 2009 Stock Incentive Plan Name of Grantee: This Notice evidences restricted stock units (each, a “RSU,” and collectively, the “RSUs”) of Unilife Corporation, a Delaware corporation (the “Company”) that have been granted to you pursuant to the Unilife Corporation Amended and Restated 2009 Stock |
|
| October 24, 2016 |
Exhibit 10.84 September 11, 2015 Molly Miller, Ph.D. 1102 Robertson Way Glenmoore, PA 19343 Re: Salary and Benefits Continuation Dear Molly: As you are aware, last week Unilife announced the initiation of a review of strategic alternatives to maximize shareholder value. Molly, you have been instrumental in building this company and are a key pillar of our organization. The Management Team and Boar |
|
| October 24, 2016 |
Exhibit 10.83 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT is made and entered into on this 21st day of October 2016, by and between Unilife Corporation ("Unilife") and Ian Hanson ("Hanson"). The term “Unilife” shall include its subsidiaries, affiliates, assigns and successors in interest under Sections 7 and 13. WHEREAS, Unilife is engaged in the business of designing, developing, manufacturing |
|
| October 24, 2016 |
Sixth AMENDMENT TO CREDIT AGREEMENT Exhibit 10.6 Sixth AMENDMENT TO CREDIT AGREEMENT This Sixth AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of February 9, 2016 by and among Unilife Medical Solutions, Inc., a Delaware corporation (the “Borrower”), the other Creditor Obligors party hereto and ROS Acquisition Offshore LP, a Cayman Islands exempted limited partnership (in its capacity as Lender and Colla |
|
| October 24, 2016 |
Exhibit 10.13 Certain portions of this Exhibit have been omitted pursuant to a request for confidentiality. Such omitted portions, which are marked with brackets [] and an asterisk*, have been separately filed with the Commission. SECURITIES PURCHASE AGREEMENT AMONG UNILIFE CORPORATION, UNILIFE MEDICAL SOLUTIONS, INC. AND AMGEN INC. DATED AS OF FEBRUARY 22, 2016 TABLE OF CONTENTS Page 1. Authoriza |
|
| October 24, 2016 |
EIGHTH AMENDMENT TO CREDIT AGREEMENT Exhibit 10.11 Certain portions of this Exhibit have been omitted pursuant to a request for confidentiality. Such omitted portions, which are marked with brackets [] and an asterisk*, have been separately filed with the Commission. EIGHTH AMENDMENT TO CREDIT AGREEMENT This EIGHTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of February 22, 2016 by and among Unilife M |
|
| October 24, 2016 |
Fifth AMENDMENT TO Royalty AGREEMENT Exhibit 10.10 Fifth AMENDMENT TO Royalty AGREEMENT This Fifth AMENDMENT TO Royalty AGREEMENT (this “Amendment”) is effective as of February 16, 2016 by and among Unilife Medical Solutions, Inc., a Delaware corporation (“Unilife”) and Royalty OPPORTUNITIES S.À R.L, a Luxembourg société à responsabilité limitée (together with its Affiliates, successors, transferees and assignees, “ROS”). WHEREAS, Un |
|
| October 24, 2016 |
Exhibit 10.56 September 30, 2016 ROS Acquisition Offshore LP Attn: Neil Gray C/O Walkers Corporate Services Limited Walker House, 87 Mary Street George Town, Grand Cayman KY 1-9005 Cayman Islands OrbiMed Advisors LLC Attn: Matthew Rizzo 601 Lexington Avenue, 54th Floor New York, NY 10022 Phone: 212.739.6400 Fax: 212.739.6444 Email: [email protected] RE:Waivers under Credit Agreement Ladies and Ge |
|
| October 24, 2016 |
Exhibit 10.82 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT is made and entered into as of this 5th day of November 2015, by and between Unilife Corporation ("Unilife") and Stephanie T. Walters ('Walters"). The term "Unilife" shall include its subsidiaries, affiliates, assigns and successors in interest under Sections 7, 8, and 13. WHEREAS, Unilife is engaged in the business of designing, develop |
|
| October 24, 2016 |
Exhibit 21 Entity Jurisdiction of Formation Unilife Medical Solutions, Inc. Delaware Unilife Cross Farm, LLC Delaware Unitract Syringe Pty Limited Australia Unilife Medical Solutions Limited Australia |
|
| October 24, 2016 |
Exhibit 10.81 AMENDMENT TO LETTER AGREEMENT THIS AMENDMENT (this “Amendment”), dated and effective as of October 13, 2015, is made by and between UNILIFE CORPORATION (“Unilife”), and MICHAEL C. RATIGAN (“Ratigan”). WHEREAS, Unilife and Ratigan have entered into a letter agreement, dated as of August 29, 2012 (the “Agreement”), as amended by an agreement dated September 10, 2015, in connection with |
|
| October 24, 2016 |
Fourth AMENDMENT TO Royalty AGREEMENT Exhibit 10.7 Fourth AMENDMENT TO Royalty AGREEMENT This Fourth AMENDMENT TO Royalty AGREEMENT (this “Amendment”) is effective as of February 9, 2016 by and among Unilife Medical Solutions, Inc., a Delaware corporation (“Unilife”) and Royalty OPPORTUNITIES S.À R.L, a Luxembourg société à responsabilité limitée (together with its Affiliates, successors, transferees and assignees, “ROS”). WHEREAS, Un |
|
| October 24, 2016 |
Exhibit 10.55 September 29, 2016 BY FACSIMILE AND FEDEX Amgen Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1799 Attention: Corporate Secretary (Fax: (805) 447-1010) Re:Waiver of Rights Under SPA and Promissory Note Ladies and Gentlemen: Reference is made herein to that certain (i) Securities Purchase Agreement (the “SPA”), dated as of February 22, 2016, by and among Unilife Corporation (“Un |
|
| October 24, 2016 |
Exhibit 10.3 January 31, 2016 Amgen Inc. One Amgen Center Drive Thousand Oaks CA 91320-1799 Attention: Corporate Secretary Re: Amendment of Exclusivity Letter Ladies and Gentlemen: Unilife Corporation (“Unilife”) and Amgen Inc. (“Amgen” and, together with Unilife, the “Parties”) have entered into an exclusivity letter agreement dated December 31, 2015 (the “Exclusivity Letter”). Capitalized terms |
|
| October 24, 2016 |
Sixth AMENDMENT TO Royalty AGREEMENT Exhibit 10.12 Certain portions of this Exhibit have been omitted pursuant to a request for confidentiality. Such omitted portions, which are marked with brackets [] and an asterisk*, have been separately filed with the Commission. Sixth AMENDMENT TO Royalty AGREEMENT This Sixth AMENDMENT TO Royalty AGREEMENT (this “Amendment”) is entered into as of February 22, 2016 by and among Unilife Medical So |
|
| October 24, 2016 |
Third AMENDMENT TO Royalty AGREEMENT EX-10.2 3 unis-ex102810.htm EX-10.2 Exhibit 10.2 Third AMENDMENT TO Royalty AGREEMENT This Third AMENDMENT TO Royalty AGREEMENT (this “Amendment”) is effective as of January 29, 2016 by and among Unilife Medical Solutions, Inc., a Delaware corporation (“Unilife”) and Royalty OPPORTUNITIES S.À R.L, a Luxembourg société à responsabilité limitée (together with its Affiliates, successors, transferees |
|
| October 24, 2016 |
Exhibit 10.80 September 10, 2015 Mr. Michael C. Ratigan 122 King Rd. Chalfont, PA 18914 Dear Mike, I am pleased to extend all of the terms of your employment set forth in the attached letter dated August 29, 2012. These terms will continue indefinitely during the course of your continued employment with Unilife, and your base compensation, target incentive compensation and equity compensation will |
|
| October 24, 2016 |
Exhibit 12.1 Calculation of Ratio of Earnings to Fixed Charges Fiscal Year Ended June 30, (In thousands) 2016 2015 2014 2013 2012 Fixed Charges: Interest expense $ 10,187 $ 6,368 $ 7,332 $ 2,392 $ 2,120 Capitalized interest 377 2,161 — — — Estimate of interest within rental expense 409 295 193 108 84 Fixed Charges $ 10,973 $ 8,824 $ 7,525 $ 2,500 $ 2,204 Earnings: Add: Loss before income taxes $ ( |
|
| October 24, 2016 |
Fifth AMENDMENT TO CREDIT AGREEMENT Exhibit 10.1 Fifth AMENDMENT TO CREDIT AGREEMENT This Fifth AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of January 31, 2016 by and among Unilife Medical Solutions, Inc., a Delaware corporation (the “Borrower”), the other Creditor Obligors party hereto and ROS Acquisition Offshore LP, a Cayman Islands exempted limited partnership (in its capacity as Lender and Colla |
|
| October 24, 2016 |
Exhibit 10.8 February 15, 2016 Amgen Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1799 Attention: Corporate Secretary Re: Amendment of Exclusivity Letter Ladies and Gentlemen: Unilife Corporation (“Unilife”) and Amgen Inc. (“Amgen” and, together with Unilife, the “Parties”) have entered into an exclusivity letter agreement dated December 31, 2015 (the “Exclusivity Letter”). Capitalized term |
|
| October 24, 2016 |
Seventh AMENDMENT TO CREDIT AGREEMENT Exhibit 10.9 Seventh AMENDMENT TO CREDIT AGREEMENT This Seventh AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of February 16 , 2016 by and among Unilife Medical Solutions, Inc., a Delaware corporation (the “Borrower”), the other Creditor Obligors party hereto and ROS Acquisition Offshore LP, a Cayman Islands exempted limited partnership (in its capacity as Lender and |
|
| October 22, 2016 |
Unilife 10-Q/A (Quarterly Report) 10-Q/A 1 d262002d10qa.htm 10-Q/A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 2 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2015 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For t |
|
| October 22, 2016 |
Awareness Letter from Independent Registered Public Accounting Firm Exhibit 15 Awareness Letter from Independent Registered Public Accounting Firm October 21, 2016 Unilife Corporation York, Pennsylvania Re: Registration Statements No. |
|
| October 22, 2016 |
Unilife 10-Q/A (Quarterly Report) 10-Q/A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 22, 2016 |
Unilife 10-K/A (Annual Report) 10-K/A 1 d261250d10ka.htm 10-K/A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2015 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period |
|
| October 21, 2016 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 17, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| October 5, 2016 |
Entry into a Material Definitive Agreement 8-K 1 d237908d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 29, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Inc |
|
| September 29, 2016 |
8-K/A 1 d278285d8ka.htm FORM 8-K AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 27, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-104935 |
|
| September 29, 2016 |
Unilife Corporation Provides Trading Update EX-99.1 Exhibit 99.1 Unilife Corporation Provides Trading Update YORK, PA, September 29, 2016 / PR Newswire/ ? Unilife Corporation (?Unilife? or the ?Company?) (NASDAQ: UNIS; ASX: UNS) announced today that the Company will not be able to file its audited financial statements by September 30, 2016. As a result, pursuant to rules of the Australian Securities Exchange (?ASX?), trading in the Company? |
|
| September 29, 2016 |
Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 27, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| September 23, 2016 |
EX-99.1 Exhibit 99.1 Unilife Corporation Announces Receipt of Delinquency Letter from NASDAQ Relating to Fiscal 2016 Form 10-K YORK, PA, September 23, 2016 / PR Newswire/ ? Unilife Corporation (?Unilife? or ?Company?) (NASDAQ: UNIS; ASX: UNS) announced today that it has received a letter (the ?NASDAQ letter?) from The NASDAQ Stock Market LLC (?NASDAQ?) notifying the Company that it is not in compl |
|
| September 23, 2016 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 19, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| September 14, 2016 |
NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 001-34540 CUSIP NUMBER: 90478E 301 (Check One): x Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form N-SAR ? Form N-CSR For Period Ended: June 30, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Form N-SAR For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form. |
|
| September 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 8, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| September 8, 2016 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 1, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 31, 2016 |
8-K 1 d241552d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 31, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorp |
|
| August 31, 2016 |
EX-99.1 Exhibit 99.1 UNILIFE CORPORATION ARBN 141 042 757 Appendix 4E ? Preliminary Final Report (Unaudited) Year Ended 30 June 2016 Explanatory Note Preliminary Nature of Results The financial information contained in this Appendix 4E (the ?Unaudited Financial Information?) of Unilife Corporation (the ?Company?) is presented on a preliminary, unaudited basis. Audited financial information for the |
|
| August 9, 2016 |
EX-10.14 Exhibit 10.14 The confidential portions of this exhibit have been filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities and Exchange Act of 1934, as amended. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN ***. Execution Copy STRICTLY CONFIDENTIAL CONFIDENTIAL TREATMENT December 31, 2015 |
|
| August 9, 2016 |
Unilife 10-Q/A (Quarterly Report) 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file |
|
| August 8, 2016 |
Exhibit 24.1 LIMITED POWER OF ATTORNEY FOR SECTION 16(a) REPORTING KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints Kevin Campbell and Stephanie Walters, as the undersigned's true and lawful attorney-in-fact (the "Attorney-in-Fact"), with full power of substitution and resubstitution, with the power to act alone for the undersigned and in the undersig |
|
| August 8, 2016 |
Exhibit 24.1 LIMITED POWER OF ATTORNEY FOR SECTION 16(a) REPORTING KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints Kevin Campbell and Stephanie Walters, as the undersigned's true and lawful attorney-in-fact (the "Attorney-in-Fact"), with full power of substitution and resubstitution, with the power to act alone for the undersigned and in the undersig |
|
| July 28, 2016 |
Appendix 4C Quarterly report for entities admitted on the basis of commitments EX-99.1 Exhibit 99.1 Appendix 4C Quarterly report for entities admitted on the basis of commitments Rule 4.7B Appendix 4C Quarterly report for entities admitted on the basis of commitments Introduced 31/3/2000. Amended 24/10/2005 Name of entity UNILIFE CORPORATION ARBN Quarter ended (current quarter) 141 042 757 30 June 16 Consolidated statement of cash flows Current quarter $US000 Year to date |
|
| July 28, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 28, 2016 (July 28, 2016) UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 28, 2016 |
Exhibit 99.1 Unilife Announces New Leadership Team and Targeted Growth Strategy Company Names New CEO and Appoints Pharma Leader to Its Board Company Focused on Executing Strategic Business Plan Internal Investigation Substantially Complete YORK, PA, July 28, 2016 / PR Newswire/ Unilife Corporation (Unilife or Company) (NASDAQ: UNIS; ASX: UNS) today announced new management and Board appoint |
|
| July 28, 2016 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 28, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 28, 2016 |
EX-99.1 Exhibit 99.1 Unilife Announces New Leadership Team and Targeted Growth Strategy Company Names New CEO and Appoints Pharma Leader to Its Board Company Focused on Executing Strategic Business Plan Internal Investigation Substantially Complete YORK, PA, July 28, 2016 / PR Newswire/ ? Unilife Corporation (?Unilife? or ?Company?) (NASDAQ: UNIS; ASX: UNS) today announced new management and Board |
|
| July 28, 2016 |
EX-10.1 2 d234369dex101.htm EX-10.1 Exhibit 10.1 RESTATED EMPLOYMENT AGREEMENT THIS RESTATED EMPLOYMENT AGREEMENT is made and entered into on this 28th day of July 2016, by and between Unilife Corporation (“Unilife”) and John C. Ryan (“Ryan”). The term “Unilife” shall include its subsidiaries, affiliates, assigns and successors in interest under Sections 7, 8, and 13. WHEREAS, Ryan and Unilife are |
|
| July 28, 2016 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 25, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 18, 2016 |
Financial Statements and Exhibits, Other Events unis-8k20160718.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 18, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Co |
|
| July 18, 2016 |
Unilife Submits Plan to Regain Compliance with NASDAQ Requirements unis-ex16.htm Exhibit 99.1 Unilife Submits Plan to Regain Compliance with NASDAQ Requirements YORK, PA, July 18, 2016 / PR Newswire/ - Unilife Corporation (?Unilife? or ?Company?) (NASDAQ: UNIS; ASX: UNS) today announced that it has submitted its plan to The NASDAQ Stock Market LLC (?NASDAQ?) to regain compliance with NASDAQ listing requirements. The Company previously received a letter from NASDA |
|
| May 31, 2016 |
SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report UNILIFE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-34540 27-1049354 (State or other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 250 Cross Farm Lane, York, Pennsylvania 17406 (Address of Principal Executiv |
|
| May 23, 2016 |
Unilife Corporation Announces Receipt of Deficiency Letter from NASDAQ unis-ex9916.htm Exhibit 99.1 Unilife Corporation Announces Receipt of Deficiency Letter from NASDAQ YORK, PA, May 23, 2016 / PR Newswire/ - Unilife Corporation (?Unilife? or ?Company?) (NASDAQ: UNIS; ASX: UNS) announced today that it has received a letter from The NADSAQ Stock Market LLC (?NASDAQ?) notifying the Company that it is not in compliance with NASDAQ Listing Rule 5250(c)(1) because it ha |
|
| May 23, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 17, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| May 12, 2016 |
8-K 1 unis-8k20160512.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 11, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorpora |
|
| May 12, 2016 |
CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF UNILIFE CORPORATION unis-ex316.htm Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF UNILIFE CORPORATION Unilife Corporation (the ?Corporation?), a corporation organized under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the ?General Corporation Law?), DOES HEREBY CERTIFY: 1. The Certificate of Incorporation of the Corporation was originally filed |
|
| May 11, 2016 |
unis-nt10q20160511.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 001-34540 CUSIP NUMBER: 90478E 103 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form N-SAR ? Form N-CSR For Period Ended: March 31, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 1 |
|
| May 10, 2016 |
Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 9, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| May 9, 2016 |
Unilife Corporation to Postpone Earnings Conference Call for Fiscal Year 2016 Third Quarter unis-ex99115.htm Exhibit 99.1 Unilife Corporation to Postpone Earnings Conference Call for Fiscal Year 2016 Third Quarter YORK, PA, May 8, 2016 / PR Newswire/ - Unilife Corporation (?Unilife? or ?Company?) (NASDAQ: UNIS; ASX: UNS) announced today that it is postponing its earnings conference call, originally scheduled to be held at 8:00 a.m. EDT on Monday, May 9, 2016 (Monday, May 9, 2016 at 10:00 |
|
| May 9, 2016 |
UNILIFE 8-K (Current Report/Significant Event) unis-8k20160508.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 8, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 3, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Pro |
|
| April 28, 2016 |
Appendix 4C Quarterly report for entities admitted on the basis of commitments EX-99.1 Exhibit 99.1 Appendix 4C Quarterly report for entities admitted on the basis of commitments Rule 4.7B Appendix 4C Quarterly report for entities admitted on the basis of commitments Introduced 31/3/2000. Amended 24/10/2005 Name of entity UNILIFE CORPORATION ARBN Quarter ended (?current quarter?) 141 042 757 31 March 16 Consolidated statement of cash flows Cash flows related to operating act |
|
| April 28, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 28, 2016 (April 28, 2016) UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| April 14, 2016 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 18, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| April 14, 2016 |
IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE EX-99.1 Exhibit 99.1 GRANTED EFiled: Mar 18 2016 11:06AM EDT Transaction ID 58739304 Case No. 9178-CB IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE CAMBRIDGE RETIREMENT SYSTEM, ) derivatively on behalf of Unilife Corporation, ) ) Plaintiff, ) v. ) ) SLAVKO JAMES JOSEPH BOSNJAK, ) JEFF CARTER, JOHN LUND, WILLIAM ) C.A. No. 9178-CB GALLE, MARY KATHERINE WOLD, ) MARC FIRESTONE, and ALAN SHORTALL, |
|
| April 4, 2016 |
DEF 14A 1 d146837ddef14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy |
|
| April 1, 2016 |
Unilife FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 31, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| March 24, 2016 |
PRE 14A 1 d146837dpre14a.htm PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy |
|
| March 22, 2016 |
UNISZ / Unilife Corp / Shortall Alan - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* Unilife Corporation (Name of issuer) Common Stock, Par Value $0.01 Per Share (Title of class of securities) 90478E 103 (CUSIP number) Alan Shortall c/o Unilife Corporation 250 Cross Farm Lane York, Pennsylvania 17406 (717) 384-3400 (Name, address and tel |
|
| March 21, 2016 |
Exhibit 24.1 LIMITED POWER OF ATTORNEY FOR SECTION 16(a) REPORTING KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints Kevin Campbell and Stephanie Walters, as the undersigned's true and lawful attorney-in-fact (the "Attorney-in-Fact"), with full power of substitution and resubstitution, with the power to act alone for the undersigned and in the undersig |
|
| March 21, 2016 |
Exhibit 24.1 LIMITED POWER OF ATTORNEY FOR SECTION 16(a) REPORTING KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints Kevin Campbell and Stephanie Walters, as the undersigned's true and lawful attorney-in-fact (the "Attorney-in-Fact"), with full power of substitution and resubstitution, with the power to act alone for the undersigned and in the undersig |
|
| March 14, 2016 |
EX-10.2 Exhibit 10.2 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the ?Agreement?) is made as of the 11th day of March, 2016 (the ?Effective Date?) by and between Alan D. Shortall (the ?Consultant?) and Unilife Corporation (the ?Company?). WHEREAS, the employment of the Consultant ended on March 11, 2016; WHEREAS, the Company and the Consultant entered into a General Release on March 11, 2016 ( |
|
| March 14, 2016 |
EX-10.1 Exhibit 10.1 March 11, 2016 Mr. Alan D. Shortall [at the address provided by Mr. Shortall] Re: General Release Dear Alan, This document is a proposed General Release (the ?Agreement? or ?Release?) from Unilife Corporation (?Unilife? or the ?Company?). Please note that some provisions of this Agreement apply whether or not you sign this Agreement whereas other provisions apply only if you s |
|
| March 14, 2016 |
8-K 1 d149716d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 11, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporatio |
|
| March 14, 2016 |
EX-99.1 Exhibit 99.1 Unilife Realigns Business Units and Leadership Team Board of Directors Appoints New Board Chair, Interim CEO and Executive Leadership Team Business Units Realigned to Focus on Key Strategic Customer Programs York, PA. ? March 14, 2016: - Unilife Corporation (NASDAQ:UNIS, ASX:UNS), a developer and supplier of injectable drug delivery systems, today announced the realignment of |
|
| March 14, 2016 |
EX-10.3 Exhibit 10.3 March 11, 2016 Ramin Mojdehbakhsh, Ph.D. [at the address provided by Dr. Mojdehbakhsh] Re: General Release Dear Ramin, This document is a proposed General Release (the ?Agreement? or ?Release?) from Unilife Corporation (?Unilife? or the ?Company?). Please note that some provisions of this Agreement apply whether or not you sign this Agreement whereas other provisions apply onl |
|
| March 3, 2016 |
Unilife SC 13G (Passive Acquisition of More Than 5% of Shares) SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* UNILIFE CORPORATION (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 90478E103 (CUSIP Number) February 22, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th |
|
| February 22, 2016 |
424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-197122 Prospectus Supplement (To Prospectus Dated October 3, 2014) Warrants to purchase 16,739,805 shares of common stock 16,739,805 shares of common stock issuable upon exercise of warrants Pursuant to this prospectus supplement and the accompanying prospectus, we are offering one or more warrants, which we refer to col |
|
| February 22, 2016 |
UNILIFE FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 22, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 22, 2016 |
EX-99.1 Exhibit 99.1 Unilife and Amgen Enter Strategic Collaboration for Injectable Drug Delivery Systems Amgen to invest up to $75 million in leading technology platform Collaboration includes license agreement and master development and supply agreement York, PA. ? February 22, 2016: Unilife Corporation (NASDAQ:UNIS, ASX:UNIS) today announced a strategic collaboration with Amgen (NASDAQ:AMGN), a |
|
| February 16, 2016 |
Entry into a Material Definitive Agreement Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 9, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 12, 2016 |
UNIS / Unilife Corp / FRONTIER CAPITAL MANAGEMENT CO LLC - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2) UNILIFE CORP. (Name of Issuer) COMMON STOCKS (Title of Class of Securities) 90478E103 (CUSIP Number) DECEMBER 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi |
|
| February 10, 2016 |
Unilife Corporation Announces Financial Results For the Second Quarter of Fiscal Year 2016 EX-99.1 2 d136643dex991.htm EX-99.1 Exhibit 99.1 Unilife Corporation Announces Financial Results For the Second Quarter of Fiscal Year 2016 York, PA (February 9, 2016) — Unilife Corporation (“Unilife” or “Company”) (NASDAQ:UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results for the second quarter of fiscal 2016 (three months ended De |
|
| February 10, 2016 |
Exhibit 10.14 The confidential portions of this exhibit have been filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities and Exchange Act of 1934, as amended. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN ***. Execution Copy STRICTLY CONFIDENTIAL December 31, 2015 Unilife Corporation 250 Cross F |
|
| February 10, 2016 |
Form 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 001-34540 CUSIP NUMBER: 90478E 103 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form N-SAR ? Form N-CSR For Period Ended: December 31, 2015 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Form N-SAR For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form. |
|
| February 10, 2016 |
EX-99.2 Exhibit 99.2 UNILIFE CORPORATION ARBN 141 042 757 Appendix 4D ? Half Year Report Six months ended 31 December 2015 Results for announcement to the market UNILIFE CORPORATION HIGHLIGHTS Results for Announcement to the Market Six Months Ended 31 December 2015 US$000?s Six Months Ended 31 December 2014 US$000?s Revenues from ordinary activities Up 13.3 % to 7,686 6,783 Profit (loss) from ordi |
|
| February 10, 2016 |
UNILIFE FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 9, 2016 (February 9, 2016) UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 10, 2016 |
Awareness Letter from Independent Registered Public Accounting Firm EX-15 Exhibit 15 Awareness Letter from Independent Registered Public Accounting Firm February 9, 2016 Unilife Corporation York, Pennsylvania Re: Registration Statements No. |
|
| February 10, 2016 |
UNISZ / Unilife Corp 10-Q - Quarterly Report - FORM 10-Q Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 8, 2016 |
Entry into a Material Definitive Agreement 8-K 1 d121885d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 5, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incor |
|
| February 5, 2016 |
UNILIFE FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 4, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 5, 2016 |
UNISZ / Unilife Corp / Shortall Alan - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* Unilife Corporation (Name of issuer) Common Stock, Par Value $0.01 Per Share (Title of class of securities) 90478E 103 (CUSIP number) Alan Shortall Chief Executive Officer Unilife Corporation 250 Cross Farm Lane York, Pennsylvania 17406 (717) 38 |
|
| February 5, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, fo |
|
| February 3, 2016 |
FIRST AMENDMENT TO STOCK PURCHASE AGREEMENT EX-10.1 Exhibit 10.1 FIRST AMENDMENT TO STOCK PURCHASE AGREEMENT This First Amendment (?Amendment?) to the Stock Purchase Agreement (?Agreement?) made and entered into on November 9, 2015, by and between Unilife Corporation, a Delaware corporation (?Company?), and Discover Growth Fund, a Cayman Islands exempted mutual fund (?Investor?) is made and entered into on February 3, 2016 (?Effective Date? |
|
| February 3, 2016 |
UNILIFE 8-K (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 3, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| February 1, 2016 |
Entry into a Material Definitive Agreement 8-K 1 d119946d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 31, 2016 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporat |
|
| January 29, 2016 |
Appendix 4C Quarterly report for entities admitted on the basis of commitments EX-99.1 Exhibit 99.1 Appendix 4C Quarterly report for entities admitted on the basis of commitments Rule 4.7B Appendix 4C Quarterly report for entities admitted on the basis of commitments Introduced 31/3/2000. Amended 24/10/2005 Name of entity UNILIFE CORPORATION ARBN Quarter ended (?current quarter?) 141 042 757 31 December 15 Consolidated statement of cash flows Cash flows related to operating |
|
| January 29, 2016 |
UNILIFE 8-K (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 29, 2016 (January 29, 2016) UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| January 7, 2016 |
FOURTH AMENDMENT TO CREDIT AGREEMENT EX-10.1 Exhibit 10.1 FOURTH AMENDMENT TO CREDIT AGREEMENT This FOURTH AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?) is made and entered into as of December 31, 2015 by and among UNILIFE MEDICAL SOLUTIONS, INC., a Delaware corporation (the ?Borrower?), the other Creditor Obligors party hereto and ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership (in its capacity as Lende |
|
| January 7, 2016 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 d117888d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 31, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Inco |
|
| January 4, 2016 |
Entry into a Material Definitive Agreement 8-K 1 d110258d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 31, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorpora |
|
| December 16, 2015 |
DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, fo |
|
| December 11, 2015 |
UNISZ / Unilife Corp / Shortall Alan - AMENDMENT NO. 4 TO SCHEDULE 13D Activist Investment Amendment No. 4 to Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Unilife Corporation (Name of Issuer) Common Stock, Par Value $0.01 Per Share (Title of Class of Securities) 90478E 103 (CUSIP Number) Alan Shortall Chief Executive Officer Unilife Corporation 250 Cross Farm Lane York, Penn |
|
| December 4, 2015 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8-K 1 d52252d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 2, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorp |
|
| November 27, 2015 |
UNILIFE UNILIFE CORP - PRELIMINARY PROXY STATEMENT Unilife Corp - Preliminary Proxy Statement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 24, 2015 |
8-K 1 d73721d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 23, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incor |
|
| November 17, 2015 |
CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF UNILIFE CORPORATION. EX-3.1 Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF UNILIFE CORPORATION. Unilife Corporation (the ?Corporation?), a corporation organized and existing under and by virtue of the General Corporation Law of the state of Delaware, does hereby certify that: 1. The name of the Corporation is Unilife Corporation. 2. The Board of Directors of the Corporation duly adopted re |
|
| November 17, 2015 |
UNILIFE FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 16, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| November 9, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 d75837d10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition peri |
|
| November 9, 2015 |
8-K 1 d137313d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incor |
|
| November 9, 2015 |
AMENDMENT TO EMPLOYMENT AGREEMENT EX-10.6 4 d75837dex106.htm EX-10.6 Exhibit 10.6 AMENDMENT TO EMPLOYMENT AGREEMENT THIS AMENDMENT (this “Amendment”), dated and effective as of October 13, 2015, is made by and between UNILIFE CORPORATION (“Unilife”), and ALAN D. SHORTALL (“SHORTALL”). WHEREAS, Unilife and Shortall have entered into an employment agreement, dated as of September 30, 2011 (the “Agreement”), as amended by agreements |
|
| November 9, 2015 |
AMENDMENT TO EMPLOYMENT AGREEMENT Exhibit 10.8 AMENDMENT TO EMPLOYMENT AGREEMENT THIS AMENDMENT (this ?Amendment?), dated and effective as of October 13, 2015, is made by and between UNILIFE CORPORATION (?Unilife?), and DAVID C. HASTINGS (?Hastings?). WHEREAS, Unilife and Hastings have entered into an employment agreement, dated as of January 9, 2015 and effective February 23, 2015 (the ?Agreement?), in connection with Hastings? e |
|
| November 9, 2015 |
AMENDMENT TO EMPLOYMENT AGREEMENT Exhibit 10.10 AMENDMENT TO EMPLOYMENT AGREEMENT THIS AMENDMENT (this ?Amendment?), dated and effective as of October 13, 2015, is made by and between UNILIFE CORPORATION (?Unilife?), and JOHN C. RYAN (?Ryan?). WHEREAS, Unilife and Ryan have entered into an employment agreement, dated as of September 15, 2014 (the ?Agreement?), as amended by an agreement dated January 9, 2015, in connection with Ry |
|
| November 9, 2015 |
Up to $7,900,000 of Series A Redeemable Convertible Preferred Stock 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-197122 Prospectus Supplement (To Prospectus Dated October 3, 2014) Up to $7,900,000 of Series A Redeemable Convertible Preferred Stock We are offering directly to an institutional investor, pursuant to a stock purchase agreement, up to an aggregate of 790 shares, for up to an aggregate of $7,900,000, of our newly designa |
|
| November 9, 2015 |
EX-3.1 Exhibit 3.1 UNILIFE CORPORATION CERTIFICATE OF DESIGNATIONS OF PREFERENCES, POWERS, RIGHTS AND LIMITATIONS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK The undersigned, Alan Shortall and David C. Hastings, hereby certify that: 1. The undersigned are the Chief Executive Officer and Chief Financial Officer, respectively, of Unilife Corporation, a Delaware corporation (the ?Corporation?) |
|
| November 9, 2015 |
AMENDMENT TO EMPLOYMENT AGREEMENT Exhibit 10.7 AMENDMENT TO EMPLOYMENT AGREEMENT THIS AMENDMENT (this ?Amendment?), dated and effective as of October 13, 2015, is made by and between UNILIFE CORPORATION (?Unilife?), and RAMIN MOJDEHBAKHSH, Ph.D. (?Mojdeh?). WHEREAS, Unilife and Mojdeh have entered into an employment agreement, dated as of July 1, 2012 (the ?Agreement?), as amended by agreements dated September 12, 2013, September |
|
| November 9, 2015 |
EX-10.2 5 d137313dex102.htm EX-10.2 Exhibit 10.2 WAIVER AND CONSENT AGREEMENT This waiver and consent agreement (this “Agreement”), dated as of November 9, 2015, is entered into by and between UNILIFE CORPORATION, a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”), and relates to that certain Purchase Agreement, dated |
|
| November 9, 2015 |
Unilife Corporation Announces Financial Results For the First Quarter of Fiscal Year 2016 EX-99.1 Exhibit 99.1 Unilife Corporation Announces Financial Results For the First Quarter of Fiscal Year 2016 York, PA (November 9, 2015) Unilife Corporation (?Unilife? or ?Company?) (NASDAQ:UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results for the first quarter of fiscal 2016 (ended September 30, 2015). Morgan Stanley Process In |
|
| November 9, 2015 |
EX-10.1 Exhibit 10.1 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (?Agreement?) is made and entered into on November 9, 2015 (?Effective Date?), by and between Unilife Corporation, a Delaware corporation (?Company?), and the investor whose name appears on the signature page hereto (?Investor?). Recitals A. The parties desire that, upon the terms and subject to the conditions herein, Inve |
|
| November 9, 2015 |
Exhibit 10.4 WAIVER TO CREDIT AGREEMENT This WAIVER TO CREDIT AGREEMENT (this ?Waiver?) is made and entered into as of November 6, 2015 by and among UNILIFE MEDICAL SOLUTIONS, INC., a Delaware corporation (the ?Borrower?), the other Creditor Obligors party hereto and ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership (the ?Lender?). WHEREAS, the Borrower and the Lender are |
|
| November 9, 2015 |
UNILIFE CORPORATION WARRANT TO PURCHASE COMMON STOCK EX-10.3 Exhibit 10.3 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEM |
|
| November 9, 2015 |
AMENDMENT TO EMPLOYMENT AGREEMENT Exhibit 10.9 AMENDMENT TO EMPLOYMENT AGREEMENT THIS AMENDMENT (this “Amendment”), dated and effective as of October 13, 2015, is made by and between UNILIFE CORPORATION (“Unilife”), and DENNIS P. PYERS (“Pyers”). WHEREAS, Unilife and Pyers have entered into an employment agreement, dated as of September 10, 2015 (the “Agreement”), in connection with Pyers’ employment by Unilife; WHEREAS, Section 1 |
|
| November 9, 2015 |
PROMISSORY NOTE $600,000.00 September 30, 2015 Exhibit 10.5 PROMISSORY NOTE $600,000.00 September 30, 2015 FOR VALUE RECEIVED, Unilife Corporation, a corporation organized under the laws of the Commonwealth of Pennsylvania (the “Payor”), hereby promises to pay to Alan Shortall (the “Payee”), the principal amount of $600,000.00, together with interest on the unpaid balance of the principal amount from time to time outstanding, from September 30 |
|
| November 3, 2015 |
EX-6 Exhibit 6 LOAN AND PLEDGE AGREEMENT This Loan and Pledge Agreement is between Alan Shortall having an address of xxxxxx (“Borrower”) and Equities First Holdings, LLC, a Delaware limited liability company having a place of business at 10 West Market Street, Suite 3050, Indianapolis, IN 46204 (the “Lender”). |
|
| November 3, 2015 |
EX-99.8 9 d67983dex998.htm EX-8 Exhibit 8 ICGVE-US-UNIS-A01 6.May.15 Final Loan Agreement DATED: ALAN DENNIS SHORTALL as Borrower and ICG Venture LIMITED as Lender **************************************** LOAN AGREEMENT relating to a term loan facility of approximately US$945,000.00 **************************************** ICGVE-US-UNIS-A01 6.May.15 Final Loan Agreement TABLE OF CONTENTS Page 1. D |
|
| November 3, 2015 |
ADDENDUM TO LOAN AND PLEDGE AGREEMENT TO EXTEND TIME TO CURE DEFAULT AND ADJUST PRICING DATES EX-2 Exhibit 2 ADDENDUM TO LOAN AND PLEDGE AGREEMENT TO EXTEND TIME TO CURE DEFAULT AND ADJUST PRICING DATES This Addendum to the Loan and Pledge Agreement modifies the Notice of Default dated August 7, 2015 (“Addendum”) is by and between Equities First Holdings, LLC, a Delaware limited liability company, having an address of 10 West Market Street, Suite 3050, Indianapolis, IN 46204 (“EFH” or “Lender”) and Alan Shortall having an address of xxxxxx (the “Borrower”). |
|
| November 3, 2015 |
EX-12 Exhibit 12 DATED: ALAN DENNIS SHORTALL as Mortgagor and ICG Venture LIMITED as Lender ******************************************** SHARE MORTGAGE relating to the shares to be provided as security for a Loan of approximately US$ 2,593,500. |
|
| November 3, 2015 |
EX-3 Exhibit 3 FORBEARANCE AGREEMENT This Forbearance Agreement (the “Forbearance Agreement”) is made between Alan Shortall having an address of xxxxxx (“Borrower”) and Equities First Holdings, LLC, a Delaware limited liability company having a place of business at 10 West Market Street, Suite 3050, Indianapolis, IN 46204 (“EFH” or “Lender”). |
|
| November 3, 2015 |
EX-4 Exhibit 4 LOAN AND PLEDGE AGREEMENT This Loan and Pledge Agreement is between Alan Shortall having an address of xxxxxx (“Borrower”) and Equities First Holdings, LLC, a Delaware limited liability company having a place of business at 10 West Market Street, Suite 3050, Indianapolis, IN 46204 (the “Lender”). |
|
| November 3, 2015 |
EX-99.1 2 d67983dex991.htm EX-1 Exhibit 1 LOAN AND PLEDGE AGREEMENT This Loan and Pledge Agreement is between Alan Shortall having an address of xxxxxx (“Borrower”) and Equities First Holdings, LLC, a Delaware limited liability company having a place of business at 10 West Market Street, Suite 3050, Indianapolis, IN 46204 (the “Lender”). WITNESSETH WHEREAS, the Borrower has requested that the Lend |
|
| November 3, 2015 |
EX-99.7 8 d67983dex997.htm EX-7 Exhibit 7 FORBEARANCE AGREEMENT This Forbearance Agreement (the “Forbearance Agreement”) is made between Alan Shortall having an address of xxxxxx (“Borrower”) and Equities First Holdings, LLC, a Delaware limited liability company having a place of business at 10 West Market Street, Suite 3050, Indianapolis, IN 46204 (“EFH” or “Lender”). WHEREAS, EFH and the Borrowe |
|
| November 3, 2015 |
EX-9 Exhibit 9 ICGVE-US-UNIS-A00 6.May.15 Final Share Mortgage DATED: ALAN DENNIS SHORTALL as Mortgagor and ICG Venture LIMITED as Lender ******************************************** SHARE MORTGAGE relating to the shares to be provided as security for a Loan of approximately US$ 945,000.00 ******************************************** ICGVE-US-UNIS-A00 6.May.15 Final Share Mortgage TABLE OF CONTENT |
|
| November 3, 2015 |
EX-5 Exhibit 5 FORBEARANCE AGREEMENT This Forbearance Agreement (the “Forbearance Agreement”) is made between Alan Shortall having an address of xxxxxx (“Borrower”) and Equities First Holdings, LLC, a Delaware limited liability company having a place of business at 10 West Market Street, Suite 3050, Indianapolis, IN 46204 (“EFH” or “Lender”). |
|
| November 3, 2015 |
EX-11 Exhibit 11 ICGVE-US-UNIS-A02 16.June.15 Final Loan Agreement DATED: ALAN DENNIS SHORTALL as Borrower and ICG Venture LIMITED as Lender ********************************** LOAN AGREEMENT relating to a term loan facility of approximately US$2,593,500.00 ********************************** ICGVE-US-UNIS-A02 16.June.15 Final Loan Agreement TABLE OF CONTENTS Page 1. DEFINITIONS 1 2. FACILITY 6 3. C |
|
| November 3, 2015 |
UNISZ / Unilife Corp / Shortall Alan - SC 13D/A Activist Investment SC 13D/A 1 d67983dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Unilife Corporation (Name of issuer) Common Stock, Par Value $0.01 Per Share (Title of class of securities) 90478E 103 (CUSIP number) Alan Shortall Chief Executive Officer Unilife Corporation 250 Cross Farm Lane York |
|
| November 3, 2015 |
EX-10 Exhibit 10 From: FP Ventures Limited Date: (Formerly known as ICG Venture Limited) Attn: Mr. |
|
| October 30, 2015 |
Appendix 4C Quarterly report for entities admitted on the basis of commitments EX-99.1 2 d25997dex991.htm EX-99.1 Exhibit 99.1 October 30, 2015 On behalf of Unilife Corporation (“Unilife” or “the Company”) (NASDAQ: UNIS; ASX: UNS), I am pleased to attach the Appendix 4C Quarterly Report for the First Fiscal Quarter of 2016 ended September 30, 2015. An earnings call where Unilife management and I will discuss the financial results for the First Fiscal Quarter of 2016, and pro |
|
| October 30, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 d25997d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 29, 2015 (October 29, 2015) UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jur |
|
| October 16, 2015 |
THIRD AMENDMENT TO CREDIT AGREEMENT EX-10.1 Exhibit 10.1 THIRD AMENDMENT TO CREDIT AGREEMENT This THIRD AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?) is made and entered into as of October 13, 2015 by and among UNILIFE MEDICAL SOLUTIONS, INC., a Delaware corporation (the ?Borrower?), the other Creditor Obligors party hereto and ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership (in its capacity as Lender a |
|
| October 16, 2015 |
EX-99.1 5 d85878dex991.htm EX-99.1 Exhibit 99.1 Unilife Announces Additional Financing of up to $10 Million from OrbiMed and Implements an Additional Cost Reduction Initiative YORK, Pa., October 16, 2015/PRNewswire/ — Unilife Corporation (“Unilife” or “Company”) (NASDAQ: UNIS, ASX: UNS) today announced the signing of an agreement with an affiliate of OrbiMed for the provision of up to an additiona |
|
| October 16, 2015 |
SECOND AMENDMENT TO ROYALTY AGREEMENT EX-10.2 Exhibit 10.2 SECOND AMENDMENT TO ROYALTY AGREEMENT This SECOND AMENDMENT TO ROYALTY AGREEMENT (this ?Amendment?) is made and entered into as of October 13, 2015 by and among UNILIFE MEDICAL SOLUTIONS, INC., a Delaware corporation (the ?Unilife?) and ROYALTY OPPORTUNITIES S.? R.L, a Luxembourg soci?t? ? responsabilit? limit?e (together with its Affiliates, successors, transferees and assign |
|
| October 16, 2015 |
AMENDED AND RESTATED PROMISSORY NOTE Up to $70,000,000 October 13, 2015 EX-10.3 Exhibit 10.3 AMENDED AND RESTATED PROMISSORY NOTE Up to $70,000,000 October 13, 2015 FOR VALUE RECEIVED, UNILIFE MEDICAL SOLUTIONS, INC., a Delaware corporation (the ?Borrower?), hereby promises to pay to the order of ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership (together with its Affiliates, successors, transferees and assigns, the ?Lender?), on the Maturity |
|
| October 16, 2015 |
UNILIFE FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 13, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| October 7, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 30, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| October 2, 2015 |
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 21, 2015 |
PRE14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 18, 2015 |
Costs Associated with Exit or Disposal Activities Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 9, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| September 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 14, 2015 |
SECOND AMENDMENT TO CREDIT AGREEMENT Exhibit 10.43 SECOND AMENDMENT TO CREDIT AGREEMENT This SECOND AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of June 30, 2015 by and among UNILIFE MEDICAL SOLUTIONS, INC., a Delaware corporation (the “Borrower”), the other Creditor Obligors party hereto and ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership (the “Lender”). WHEREAS, the Borrowe |
|
| September 14, 2015 |
Exhibit 10.44 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT is made and entered into as of this 10th day of September 2015, by and between Unilife Corporation (?Unilife?) and Dennis P. Pyers (?Pyers?). The term ?Unilife? shall include its subsidiaries, affiliates, assigns and successors in interest under Sections 7, 8, and 13. WHEREAS, Unilife is engaged in the business of designing, developing, |
|
| September 14, 2015 |
Unilife Medical Solutions, Inc. Exhibit 21 Entity Jurisdiction of Formation Unilife Medical Solutions, Inc. Delaware Unilife Cross Farm, LLC Delaware Unitract Syringe Pty Limited Australia Unilife Medical Solutions Limited Australia |
|
| September 14, 2015 |
EX-12.1 Exhibit 12.1 Calculation of Ratio of Earnings to Fixed Charges Fiscal Year Ended June 30, (In thousands) 2015 2014 2013 2012 2011 Fixed Charges: Interest expense $ 6,368 $ 7,332 $ 2,392 $ 2,120 $ 511 Capitalized interest 2,161 — — — 323 Estimate of interest within rental expense 295 193 108 84 217 Fixed Charges $ 8,824 $ 7,525 $ 2,500 $ 2,204 $ 1,051 Earnings: Add: Loss before income taxes |
|
| September 14, 2015 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 14, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| September 14, 2015 |
EX-99.1 Exhibit 99.1 Unilife Corporation Announces Financial Results For the Fourth Quarter and Full Fiscal Year 2015 * * * Significant cost reduction and business realignment initiative implemented York, PA (September 14, 2015) Unilife Corporation (?Unilife? or ?Company?) (NASDAQ:UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results f |
|
| September 3, 2015 |
Exhibit 24 LIMITED POWER OF ATTORNEY FOR SECTION 16(a) REPORTING KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints John Ryan and Deborah Karlak, as the undersigned's true and lawful attorney-in-fact (the "Attorney-in Fact"), with full power of substitution and resubstitution, with the power to act alone for the undersigned and in the undersigned's name, place and stead, in any and all capacities to: 1. |
|
| September 2, 2015 |
EX-99.1 Exhibit 99.1 Unilife Announces Review of Strategic Alternatives Morgan Stanley Appointed as Strategic Advisor in Response to Expressions of Interest from Third Parties York, PA. ? September 2, 2015. Unilife Corporation (?Unilife? or the ?Company?) (NASDAQ: UNIS and ASX: UNS), a developer, manufacturer and supplier of injectable drug delivery systems, today announced that in response to thi |
|
| September 2, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 2, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 31, 2015 |
EX-99.1 Exhibit 99.1 UNILIFE CORPORATION ARBN 141 042 757 Appendix 4E ? Preliminary Final Report Year Ended 30 June 2015 Results for Announcement to the Market UNILIFE CORPORATION HIGHLIGHTS Results for Announcement to the Market Year Ended 30 June 2015 Year Ended 30 June 2014 (US$, in thousands) Revenues from ordinary activities Down 10 % to 13,158 14,689 Loss from ordinary activities after tax a |
|
| August 31, 2015 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 31, 2015 (August 31, 2015) UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 28, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 26, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 25, 2015 |
UNILIFE FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 24, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| August 19, 2015 |
Former Employee Issues Apology and Withdraws Whistleblower Lawsuit EX991 Exhibit 99.1 Former Employee Issues Apology and Withdraws Whistleblower Lawsuit York, PA. ? August 19, 2015 ? Unilife Corporation (NASDAQ: UNIS and ASX: UNS), a developer, manufacturer and supplier of injectable drug delivery systems, today announced that a former employee has agreed to dismiss all of his claims against the Company and has issued a public apology for bringing his claims. The |
|
| August 19, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 19, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 31, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 28, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 30, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 29, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 30, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 29, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 30, 2015 |
EX-99.1 July 30, 2015 Unilife Conference Call Exhibit 99.1 2 Cautionary Note Regarding Forward-Looking Statements This presentation dated July 30, 2015 has been prepared by Unilife Corporation ("Unilife or Company") (NASDAQ: UNIS; ASX: UNIS). Statements and information in this presentation are current only as at July 30, 2015 and the information in this presentation remains subject to change witho |
|
| July 30, 2015 |
EX-10.1 Exhibit 10.1 UNILIFE CORPORATION Shares of Common Stock (par value $0.01 per share) Controlled Equity OfferingSM Sales Agreement July 29, 2015 Cantor Fitzgerald & Co. 499 Park Avenue New York, NY 10022 Ladies and Gentlemen: Unilife Corporation, a Delaware corporation (the ?Company?), confirms its agreement (this ?Agreement?) with Cantor Fitzgerald & Co. (the ?Agent?), as follows: 1. Issuan |
|
| July 30, 2015 |
ISSUER FREE WRITING PROSPECTUS DATED JULY 29, 2015 UNILIFE CORPORATION FWP Issuer Free Writing Prospectus filed pursuant to Rule 433 supplementing the Prospectus dated October 3, 2014 Registration No. |
|
| July 30, 2015 |
Up to $25,000,000 Common Stock 424(b)(5) Table of Contents Filed pursuant to Rule 424(b)(5) Registration No. 333-197122 Prospectus Supplement (To Prospectus dated October 3, 2014) Up to $25,000,000 Common Stock We have entered into a Controlled Equity OfferingSM sales agreement with Cantor Fitzgerald & Co., or Cantor, relating to shares of our common stock offered by this prospectus supplement and the accompanying prospectus. I |
|
| July 30, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 29, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 30, 2015 |
Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 29, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 30, 2015 |
424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-197122 PROSPECTUS SUPPLEMENT (To Prospectus dated October 3, 2014) $45,900,000 Common Stock This prospectus supplement relates to the issuance and sale of up to $45,900,000 in shares of our common stock to Lincoln Park Capital Fund, LLC, or Lincoln Park, under a Purchase Agreement entered into on July 29, 2015, or the Pu |
|
| July 30, 2015 |
EX-10.1 Exhibit 10.1 PURCHASE AGREEMENT PURCHASE AGREEMENT (the ?Agreement?), dated as of July 29, 2015, by and between UNILIFE CORPORATION, a Delaware corporation, (the ?Company?), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the ?Investor?). WHEREAS: Subject to the terms and conditions set forth in this Agreement, the Company wishes to sell to the Investor, and the |
|
| July 30, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 30, 2015 (July 30, 2015) UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| July 30, 2015 |
Appendix 4C Quarterly report for entities admitted on the basis of commitments EX-99.1 Exhibit 99.1 Appendix 4C Quarterly report for entities admitted on the basis of commitments Rule 4.7B Appendix 4C Quarterly report for entities admitted on the basis of commitments Introduced 31/3/2000. Amended 24/10/2005 Name of entity UNILIFE CORPORATION ARBN Quarter ended (?current quarter?) 141 042 757 30 June 15 Consolidated statement of cash flows Cash flows related to operating acti |
|
| July 1, 2015 |
UNILIFE FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 30, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| June 19, 2015 |
Submission of Matters to a Vote of Security Holders 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 17, 2015 UNILIFE CORPORATION (Exact name of Registrant as Specified in Charter) Delaware 001-34540 27-1049354 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
